NC
EVH icon

Nicholas Company’s Evolent Health EVH Stock Holding History

Nicholas Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-249,935
Closed -$4.99M – 220
2018
Q4 		$4.99M Buy
249,935
+196,705
+370% +$4.55M 0.13% 174
2018
Q3 		$1.51M Buy
+53,230
New +$1.27M 0.03% 222

Other funds holding EVH

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Nicholas Company's EVH Position: Q1 2019 in Review

Nicholas Company sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 249,935 shares — an estimated $4.99M sold.

Nicholas Company first reported a position in EVH in Q3 2018 and held it in 2 quarters. The position peaked at $4.99M in Q4 2018. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

  • Nicholas Company reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
  • Nicholas Company sold 249,935 Evolent Health shares in Q1 2019, an estimated $4.99M.
  • Nicholas Company first reported a position in Evolent Health in Q3 2018 and held it in 2 quarters.
  • Nicholas Company's Evolent Health position peaked at $4.99M in Q4 2018.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on Nicholas Company's 13F filing for Q1 2019, filed 14 May 2019.